Home/Pipeline/Combined Agluna® – Acusure Ag®

Combined Agluna® – Acusure Ag®

Dual-action infection prevention and bone integration for high-risk implants

CommercialLaunched and available

Key Facts

Indication
Dual-action infection prevention and bone integration for high-risk implants
Phase
Commercial
Status
Launched and available
Company

About Accentus Medical

Accentus Medical is a leading medical technology company with over 20 years of expertise in developing and supplying advanced surface coating technologies for implantable devices. Its core technologies—Acusure® plasma spray coatings and Agluna®/Acusure Ag® silver antimicrobial treatments—are designed to improve bone/tissue integration and reduce post-operative infection risks. The company operates from the Harwell Campus innovation hub, collaborates globally with major device manufacturers, and has recently been acquired by the STS Group, marking a new chapter in its growth.

View full company profile